Welcome to our dedicated page for Prestige Consmr Healthcare SEC filings (Ticker: PBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Prestige Consumer Healthcare Inc. filings document material events for an operating consumer healthcare company, including 8-K disclosures on quarterly and year-to-date operating results, financial condition and Regulation FD investor presentations. The filings also cover material agreements, capital-structure matters, governance topics and shareholder voting matters tied to the company’s public-company reporting.
These records frame Prestige’s disclosures around its portfolio of over-the-counter healthcare brands, retail distribution markets, and product or regulatory matters when they are material to the business.
Prestige Consumer Healthcare CFO & COO Christine Sacco reported a tax-related share disposition. On May 5, 2026, 1,267 shares of common stock were withheld at $55.75 per share to cover tax obligations. After this non‑market transaction, she directly owned 72,627 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare Inc. Chief Executive Officer Ronald M. Lombardi reported a routine tax-related share disposition. On the reported date, 2,197 shares of common stock were delivered at $55.75 per share to satisfy a tax liability. Following this tax-withholding disposition, he directly holds 376,008 shares of Prestige Consumer Healthcare common stock.
PBH reports a Form 144 filing for the proposed sale of 305 shares of Common Stock linked to restricted stock vesting on 05/05/2026. The filing also lists recent sales by Jeffrey A. Zerillo: 1,000 shares on 02/11/2026, 346 shares on 05/05/2026, and 1,207 shares on 05/06/2026.
Prestige Consumer Healthcare Inc. reported that CFO & COO Christine Sacco received equity compensation and related tax withholding transactions in company stock. She acquired 11,976 shares of common stock upon settlement of performance stock units granted on May 5, 2023, which vested on May 4, 2026 based on per share growth goals. She also received a 7,008‑share restricted stock award that vests in three equal installments of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029. To cover tax obligations, 3,434 shares were withheld at $55.31 per share. After these transactions, she directly holds 61,918 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare executive William P’Pool reported equity compensation awards and related tax withholding in common stock. On May 4, 2026, 4,187 shares settled from previously granted performance stock units based on per share growth goals, and 3,675 Restricted Stock Units were awarded at no cost. To cover tax obligations, 1,888 shares were withheld at $55.31 per share. After these transactions, P’Pool directly holds 25,850 common shares, and 100 additional shares are held indirectly in the P’Pool Family Giving Fund.
Prestige Consumer Healthcare Senior VP of Operations Jeffrey Zerillo reported routine equity compensation activity and a small share sale. He received stock awards of 2,857 and 2,450 common shares at no cost, reflecting PSU settlement and RSU grants. To cover tax obligations, 1,243 shares were disposed of, and he later sold 346 shares in an open-market transaction at about $55.32 per share. After these transactions, he directly holds 44,334 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare EVP of Marketing & Sales Adel Mekhail reported equity compensation activity. On May 4, 2026, he acquired 4,014 shares of common stock through settlement of performance stock units that vested based on per share growth goals, and received 3,505 shares of restricted stock.
The company withheld 1,695 shares at $55.31 per share to cover tax obligations, a non‑market disposition. Following these transactions, Mekhail directly owns 23,871 common shares. The restricted stock is scheduled to vest in three equal installments of 1,338 shares on May 4, 2027, May 4, 2028 and May 4, 2029.
Prestige Consumer Healthcare Inc. reported equity compensation changes for Chief Executive Officer Ronald M. Lombardi. He acquired 19,662 shares of common stock on settlement of performance stock units that vested on May 4, 2026 based on per share growth goals, and received a separate grant of 31,468 Restricted Stock Units.
To cover tax obligations, 16,789 shares were disposed of at $55.31 per share through a tax-withholding mechanism rather than an open-market sale. Following these transactions, Lombardi directly holds 358,543 shares of Prestige Consumer Healthcare common stock. The new Restricted Stock Units vest in three equal installments of 6,554 shares in 2027, 2028 and 2029.
PBH insider submitted a Form 144 reporting proposed sales of Common Stock. The notice lists a proposed transaction through Fidelity Brokerage Services and references a Restricted Stock Vesting event dated 05/04/2026. The filing also reports prior dispositions of 1,000 shares on 02/11/2026 and 346 shares on 05/05/2026, with dollar amounts shown for those sales.
Prestige Consumer Healthcare Inc. executive Christine Sacco, the company’s CFO & COO, reported a tax-related share disposition. She had 1,091 shares of common stock withheld at $55.09 per share to cover tax obligations, a non-market transaction. After this withholding, she directly holds 58,344 common shares.